LDHB and cancer: It was not until the recent availability of multiplex LDH isoform inhibitors (LDHA, LDHB, LDHC, and LDHD) or combined silencing models—where lactic acid in a cancer model was blocked for the first time—enabling study of how cancer cells survive without lactic acid acidity, which independently is a known integral role in metastasis and immune evasion [12,13].